Most Read Articles
Jairia Dela Cruz, 6 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, Yesterday
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.

Inflatable penis prostheses remain effective for decades

28 Nov 2019

Inflatable penis prostheses (IPPs) have good longevity, with around half of the implants functioning properly even after 20 years, a recent study has found.

The study included 51 patients (median age, 51 years) who received IPPs and who were followed-up after a median of 206 months. Outcomes included complications and functional measures, as well as quality of life, assessed using the Quality of Life and Sexuality with Penile Prosthesis (QoLSPP) inventory.

Over the follow-up period, 31 participants stopped using the prosthesis. Majority (n=24; 78 percent) were due to complications such as mechanical failure (n=19), pain (n=3) and orgasmic interference (n=1). Other reasons for discontinuation included having issues with their partners (n=4) and advanced age (n=3).

Kaplan-Meier analysis found that prosthesis survival at 5 years was 96 percent. This dropped to 86 percent by 10 years and to 53 percent by 20 years. At the 20-year timepoint, the estimated probability that the prosthesis would be regularly used was 62 percent.

Notably, those still using the device at follow-up showed median scores in the functional, relational, personal and social domains of the QoLSPP. The total QoLSPP score was 70 out of 80 points.

It is worth noting, however, that most of the patients experienced IPP failure (67 percent; n=34). Despite this, majority still opted to have the device replaced (n=16).

These findings emphasize the sustained, long-term benefits associated with using IPPs, said researchers. This may help both doctors and their patients make more informed decisions about the implant.

Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 6 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, Yesterday
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.